Hydrolyzed Infant Formula - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245079

Publication Date:

October 29, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Food Processing [2]

Food [3]

Food & Beverages [4]

Description:

Extensively听hydrolyzed formulas听offer complete听nutrition听for听infants听who are allergic to cow's milk protein. Casein is a cow's milk protein that is a common cause for allergy symptoms. Extensively听hydrolyzed formulas听break casein into pieces. About 90% of babies with cow's milk allergy will tolerate these听formulas.
The global market for Hydrolyzed Infant Formula was estimated to be worth US$ 753 million in 2023 and is forecast to a readjusted size of US$ 1288.9 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is 楼17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is 楼485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hydrolyzed Infant Formula, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hydrolyzed Infant Formula by region & country, by Type, and by Application.
The Hydrolyzed Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydrolyzed Infant Formula.
Market Segmentation
By Company
Nestle
Danone Nutricia
Abbott
Mead Johnson
Beingmate
Synutra International
Maeil
Segment by Type:
Completely Hydrolyzed
Partially Hydrolyzed
Segment by Application
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hydrolyzed Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hydrolyzed Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hydrolyzed Infant Formula in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Hydrolyzed Infant Formula Product Introduction
1.2 Global Hydrolyzed Infant Formula Market Size Forecast
1.2.1 Global Hydrolyzed Infant Formula Sales Value (2019-2030)
1.2.2 Global Hydrolyzed Infant Formula Sales Volume (2019-2030)
1.2.3 Global Hydrolyzed Infant Formula Sales Price (2019-2030)
1.3 Hydrolyzed Infant Formula Market Trends & Drivers
1.3.1 Hydrolyzed Infant Formula Industry Trends
1.3.2 Hydrolyzed Infant Formula Market Drivers & Opportunity
1.3.3 Hydrolyzed Infant Formula Market Challenges
1.3.4 Hydrolyzed Infant Formula Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hydrolyzed Infant Formula Players Revenue Ranking (2023)
2.2 Global Hydrolyzed Infant Formula Revenue by Company (2019-2024)
2.3 Global Hydrolyzed Infant Formula Players Sales Volume Ranking (2023)
2.4 Global Hydrolyzed Infant Formula Sales Volume by Company Players (2019-2024)
2.5 Global Hydrolyzed Infant Formula Average Price by Company (2019-2024)
2.6 Key Manufacturers Hydrolyzed Infant Formula Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hydrolyzed Infant Formula Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hydrolyzed Infant Formula
2.9 Hydrolyzed Infant Formula Market Competitive Analysis
2.9.1 Hydrolyzed Infant Formula Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hydrolyzed Infant Formula Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydrolyzed Infant Formula as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Completely Hydrolyzed
3.1.2 Partially Hydrolyzed
3.2 Global Hydrolyzed Infant Formula Sales Value by Type
3.2.1 Global Hydrolyzed Infant Formula Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hydrolyzed Infant Formula Sales Value, by Type (2019-2030)
3.2.3 Global Hydrolyzed Infant Formula Sales Value, by Type (%) (2019-2030)
3.3 Global Hydrolyzed Infant Formula Sales Volume by Type
3.3.1 Global Hydrolyzed Infant Formula Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hydrolyzed Infant Formula Sales Volume, by Type (2019-2030)
3.3.3 Global Hydrolyzed Infant Formula Sales Volume, by Type (%) (2019-2030)
3.4 Global Hydrolyzed Infant Formula Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Online
4.1.2 Offline
4.2 Global Hydrolyzed Infant Formula Sales Value by Application
4.2.1 Global Hydrolyzed Infant Formula Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hydrolyzed Infant Formula Sales Value, by Application (2019-2030)
4.2.3 Global Hydrolyzed Infant Formula Sales Value, by Application (%) (2019-2030)
4.3 Global Hydrolyzed Infant Formula Sales Volume by Application
4.3.1 Global Hydrolyzed Infant Formula Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hydrolyzed Infant Formula Sales Volume, by Application (2019-2030)
4.3.3 Global Hydrolyzed Infant Formula Sales Volume, by Application (%) (2019-2030)
4.4 Global Hydrolyzed Infant Formula Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hydrolyzed Infant Formula Sales Value by Region
5.1.1 Global Hydrolyzed Infant Formula Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hydrolyzed Infant Formula Sales Value by Region (2019-2024)
5.1.3 Global Hydrolyzed Infant Formula Sales Value by Region (2025-2030)
5.1.4 Global Hydrolyzed Infant Formula Sales Value by Region (%), (2019-2030)
5.2 Global Hydrolyzed Infant Formula Sales Volume by Region
5.2.1 Global Hydrolyzed Infant Formula Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hydrolyzed Infant Formula Sales Volume by Region (2019-2024)
5.2.3 Global Hydrolyzed Infant Formula Sales Volume by Region (2025-2030)
5.2.4 Global Hydrolyzed Infant Formula Sales Volume by Region (%), (2019-2030)
5.3 Global Hydrolyzed Infant Formula Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hydrolyzed Infant Formula Sales Value, 2019-2030
5.4.2 North America Hydrolyzed Infant Formula Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hydrolyzed Infant Formula Sales Value, 2019-2030
5.5.2 Europe Hydrolyzed Infant Formula Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hydrolyzed Infant Formula Sales Value, 2019-2030
5.6.2 Asia Pacific Hydrolyzed Infant Formula Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hydrolyzed Infant Formula Sales Value, 2019-2030
5.7.2 South America Hydrolyzed Infant Formula Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hydrolyzed Infant Formula Sales Value, 2019-2030
5.8.2 Middle East & Africa Hydrolyzed Infant Formula Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hydrolyzed Infant Formula Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hydrolyzed Infant Formula Sales Value
6.2.1 Key Countries/Regions Hydrolyzed Infant Formula Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hydrolyzed Infant Formula Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hydrolyzed Infant Formula Sales Value, 2019-2030
6.3.2 United States Hydrolyzed Infant Formula Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hydrolyzed Infant Formula Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hydrolyzed Infant Formula Sales Value, 2019-2030
6.4.2 Europe Hydrolyzed Infant Formula Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hydrolyzed Infant Formula Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hydrolyzed Infant Formula Sales Value, 2019-2030
6.5.2 China Hydrolyzed Infant Formula Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hydrolyzed Infant Formula Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hydrolyzed Infant Formula Sales Value, 2019-2030
6.6.2 Japan Hydrolyzed Infant Formula Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hydrolyzed Infant Formula Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hydrolyzed Infant Formula Sales Value, 2019-2030
6.7.2 South Korea Hydrolyzed Infant Formula Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hydrolyzed Infant Formula Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hydrolyzed Infant Formula Sales Value, 2019-2030
6.8.2 Southeast Asia Hydrolyzed Infant Formula Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hydrolyzed Infant Formula Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hydrolyzed Infant Formula Sales Value, 2019-2030
6.9.2 India Hydrolyzed Infant Formula Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hydrolyzed Infant Formula Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Nestle
7.1.1 Nestle Company Information
7.1.2 Nestle Introduction and Business Overview
7.1.3 Nestle Hydrolyzed Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Nestle Hydrolyzed Infant Formula Product Offerings
7.1.5 Nestle Recent Development
7.2 Danone Nutricia
7.2.1 Danone Nutricia Company Information
7.2.2 Danone Nutricia Introduction and Business Overview
7.2.3 Danone Nutricia Hydrolyzed Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Danone Nutricia Hydrolyzed Infant Formula Product Offerings
7.2.5 Danone Nutricia Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Hydrolyzed Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Hydrolyzed Infant Formula Product Offerings
7.3.5 Abbott Recent Development
7.4 Mead Johnson
7.4.1 Mead Johnson Company Information
7.4.2 Mead Johnson Introduction and Business Overview
7.4.3 Mead Johnson Hydrolyzed Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Mead Johnson Hydrolyzed Infant Formula Product Offerings
7.4.5 Mead Johnson Recent Development
7.5 Beingmate
7.5.1 Beingmate Company Information
7.5.2 Beingmate Introduction and Business Overview
7.5.3 Beingmate Hydrolyzed Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Beingmate Hydrolyzed Infant Formula Product Offerings
7.5.5 Beingmate Recent Development
7.6 Synutra International
7.6.1 Synutra International Company Information
7.6.2 Synutra International Introduction and Business Overview
7.6.3 Synutra International Hydrolyzed Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Synutra International Hydrolyzed Infant Formula Product Offerings
7.6.5 Synutra International Recent Development
7.7 Maeil
7.7.1 Maeil Company Information
7.7.2 Maeil Introduction and Business Overview
7.7.3 Maeil Hydrolyzed Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Maeil Hydrolyzed Infant Formula Product Offerings
7.7.5 Maeil Recent Development
8 Industry Chain Analysis
8.1 Hydrolyzed Infant Formula Industrial Chain
8.2 Hydrolyzed Infant Formula Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hydrolyzed Infant Formula Sales Model
8.5.2 Sales Channel
8.5.3 Hydrolyzed Infant Formula Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Nestle
Danone Nutricia
Abbott
Mead Johnson
Beingmate
Synutra International
Maeil

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂